Clinical Trial Update: Comparing the Efficacy of Different Durations of Maribavir Treatment Regimens in Allo-HSCT [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update comparing different durations of maribavir treatment in patients undergoing allogeneic hematopoietic stem cell transplantation for…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancy

Drugs mentioned

• Maribavir (maribavir)

Snippet

Sponsor: Ruijin Hospital | Conditions: Hematologic Malignancy | Phase 3 | Status: RECRUITING